-
1
-
-
0020528710
-
Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-y is the activating lymphokine
-
Murray HW, Rubin BY, Rothermel CD. Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-y is the activating lymphokine. J Clin Invest 1983;72:1506-10.
-
(1983)
J Clin Invest
, vol.72
, pp. 1506-1510
-
-
Murray, H.W.1
Rubin, B.Y.2
Rothermel, C.D.3
-
2
-
-
0025266647
-
Effect of continuous administration of interferon-y in experimental visceral leishmaniasis
-
Murray HW. Effect of continuous administration of interferon-y in experimental visceral leishmaniasis. J Infect Dis 1990;161:992-4.
-
(1990)
J Infect Dis
, vol.161
, pp. 992-994
-
-
Murray, H.W.1
-
3
-
-
0030932976
-
Behavior of visceral Leishmania donovani in an experimentally induced T helper cell 2 (Th2)-associated response model
-
Murray HW, Hariprashad J, Coffman RL. Behavior of visceral Leishmania donovani in an experimentally induced T helper cell 2 (Th2)-associated response model. J Exp Med 1997;185:867-74.
-
(1997)
J Exp Med
, vol.185
, pp. 867-874
-
-
Murray, H.W.1
Hariprashad, J.2
Coffman, R.L.3
-
4
-
-
0024386420
-
Effects of intradermal γ-interferon in cutaneous leishmaniasis
-
Harms G, Zwingenberger K, Chéhadé AK, et al. Effects of intradermal γ-interferon in cutaneous leishmaniasis. Lancet 1989;1:1287-92.
-
(1989)
Lancet
, vol.1
, pp. 1287-1292
-
-
Harms, G.1
Zwingenberger, K.2
Chéhadé, A.K.3
-
5
-
-
0025139949
-
Treatment of visceral leishmaniasis with pentavalent antimony and interferon- γ
-
Badaro R, Falcoff E, Badaro FS, et al. Treatment of visceral leishmaniasis with pentavalent antimony and interferon- γ. N Engl J Med 1990;322: 16-21.
-
(1990)
N Engl J Med
, vol.322
, pp. 16-21
-
-
Badaro, R.1
Falcoff, E.2
Badaro, F.S.3
-
6
-
-
0027989603
-
Successful treatment of refractory visceral leishmaniasis in India using antimony plus interferon-γ
-
Sundar S, Rosenkaimer F, Murray HW. Successful treatment of refractory visceral leishmaniasis in India using antimony plus interferon-γ. J Infect Dis 1994;170:659-62.
-
(1994)
J Infect Dis
, vol.170
, pp. 659-662
-
-
Sundar, S.1
Rosenkaimer, F.2
Murray, H.W.3
-
7
-
-
0028844536
-
Effect of treatment with interferon- γ alone in visceral leishmaniasis
-
Sundar S, Murray HW. Effect of treatment with interferon- γ alone in visceral leishmaniasis. J Infect Dis 1995;172:1627-9.
-
(1995)
J Infect Dis
, vol.172
, pp. 1627-1629
-
-
Sundar, S.1
Murray, H.W.2
-
8
-
-
0030070831
-
Cure of antimony-unresponsive Indian visceral leishmaniasis with amphotericin B lipid complex
-
Sundar S, Murray HW. Cure of antimony-unresponsive Indian visceral leishmaniasis with amphotericin B lipid complex. J Infect Dis 1996; 173:762-5.
-
(1996)
J Infect Dis
, vol.173
, pp. 762-765
-
-
Sundar, S.1
Murray, H.W.2
-
10
-
-
0027323517
-
Interleukin 10 production correlates with pathology in human Leishmania donovani infections
-
Ghalib HW, Piuvezam MR, Skeiky YA, et al. Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J Clin Invest 1993;92:324-9.
-
(1993)
J Clin Invest
, vol.92
, pp. 324-329
-
-
Ghalib, H.W.1
Piuvezam, M.R.2
Skeiky, Y.A.3
|